Altre lingue STOXX MOROCCO TMI (EUR)

Indice

CH0147792771

Mercato chiuso - Switzerland 17:50:00 30/04/2024 Variaz. 5gg Var. 1 gen.
93,33 PTS +0,01% Grafico intraday di STOXX MOROCCO TMI (EUR) -0,11% +5,91%
Stocks Fall in Premarket Action as Traders Await More Earnings; Asia Down, Europe Mixed
Masimo Shares Tumble on Downbeat Preliminary Fiscal Second-Quarter Revenue
Masimo Adjusts Sales Forecasts as Fiscal Q2 Revenue Set to Miss Internal Projections; Shares Plunge Premarket
Masimo Says Fiscal Q2 Revenue to be Lower Than Expected, Plans to Cut Full-Year Revenue Guidance
Masimo Shareholder Says Two Nominees Elected to Board With 'Overwhelming' Support
Masimo Stockholders Poised to Elect Politan's Board Nominees
Accor cède sa participation de 33% dans Risma mais reste présent au Maroc
Masimo to Provide Health-Tracking Watch to Hospital La Fe
Sector Update: Health Care Stocks Rising Late Thursday
Sector Update: Health Care Stocks Rising in Afternoon Trading
Koninklijke Philips and Masimo get FDA Approval for Added Measurements in IntelliVue Monitoring Systems
Insider Buy: Masimo
Masimo Q1 Adjusted Earnings Fall, Revenue Jumps; 2023 Outlook Reiterated
Masimo's Health Tracking Watch Selected by Cambridge University Hospitals for Virtual Care Program
Masimo Receives FDA Clearance for Rad-G with Temperature
ROUNDUP 2:/Zeugen: Scholz widersprach sich bei 'Cum-Ex' - SPD: 'Polittheater'
Zeugen: Scholz widersprach sich bei 'Cum-Ex'-Befragungen
Zeugen: Scholz widersprach sich bei Befragungen zu 'Cum-Ex'-Affäre
De Masi im 'Cum-Ex'-Ausschuss: Ich fühlte mich von Scholz getäuscht
WOCHENVORSCHAU: Termine bis 27. April 2023
Familienministerin Paus als Zeugin im Untersuchungsausschuss zur Warburg-Affäre
Masimo Gets FDA Clearance for Opioid Overdose Prevention System
Masimo Says Its US FDA-Approved PVi Device 'Performed Well' in China Study
Masimo's Q4 Non-GAAP EPS, Revenue Advance; Guidance Issued
Earnings Flash (MASI) MASIMO Reports Q4 EPS $1.32, vs. Street Est of $1.18
(MASI) MASIMO Forecasts Fiscal Year 2023 EPS Range $4.70 - $4.80
(MASI) MASIMO Forecasts Q1 EPS Range $0.81 - $0.86
(MASI) MASIMO Forecasts Q1 Revenue Range $550M - $565M
(MASI) MASIMO Expects Fiscal Year 2023 Revenue Range $2.42B - $2.46B
Masimo Launches Product for Hand Hygiene Compliance in Hospitals
Masimo, Philips Expand Technology Partnership
Sector Update: Tech Stocks Advancing During Wednesday Trading
Sector Update: Tech Stocks Advancing Wednesday but Chipmakers Lag
Sector Update: Tech
Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent
Sector Update: Health Care Stocks Flat to Higher Premarket Wednesday
Fresh Inflation Data Eyed as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednesday
Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent
Rainwater Tech to list in New York via SPAC merger
Masimo Issues Fiscal 2023 Outlook
Wirecard : procès d'une fraude financière sans précédent en Allemagne
Brokers, investors back Chinese state firms, toeing Beijing's line
Masimo Shares Higher as Court Rules Former Executive Guilty of Stealing Trade Secrets
Insider Buy: Masimo
Insider Buy: Masimo